176 related articles for article (PubMed ID: 25800988)
21. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
[TBL] [Abstract][Full Text] [Related]
22. Pulsed electromagnetic field inhibits RANKL-dependent osteoclastic differentiation in RAW264.7 cells through the Ca
Zhang J; Xu H; Han Z; Chen P; Yu Q; Lei Y; Li Z; Zhao M; Tian J
Biochem Biophys Res Commun; 2017 Jan; 482(2):289-295. PubMed ID: 27856256
[TBL] [Abstract][Full Text] [Related]
23. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
24. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
25. Role of calcineurin, hnRNPA2 and Akt in mitochondrial respiratory stress-mediated transcription activation of nuclear gene targets.
Guha M; Tang W; Sondheimer N; Avadhani NG
Biochim Biophys Acta; 2010; 1797(6-7):1055-65. PubMed ID: 20153290
[TBL] [Abstract][Full Text] [Related]
26. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
27. Staphylococcus aureus Protein A induces osteoclastogenesis via the NF‑κB signaling pathway.
Ren LR; Wang H; He XQ; Song MG; Chen XQ; Xu YQ
Mol Med Rep; 2017 Nov; 16(5):6020-6028. PubMed ID: 28849198
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome c oxidase dysfunction enhances phagocytic function and osteoclast formation in macrophages.
Angireddy R; Kazmi HR; Srinivasan S; Sun L; Iqbal J; Fuchs SY; Guha M; Kijima T; Yuen T; Zaidi M; Avadhani NG
FASEB J; 2019 Aug; 33(8):9167-9181. PubMed ID: 31063702
[TBL] [Abstract][Full Text] [Related]
29. Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Li L; Sapkota M; Kim SW; Soh Y
Eur J Pharmacol; 2016 Apr; 777():17-25. PubMed ID: 26923730
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
31. TNFα Increases RANKL Expression via PGE₂-Induced Activation of NFATc1.
Park HJ; Baek K; Baek JH; Kim HR
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245593
[TBL] [Abstract][Full Text] [Related]
32. Activation of protein kinase C accelerates murine osteoclastogenesis partly via transactivation of RANK gene through functional AP-1 responsive element in RANK gene promoter.
Kitazawa R; Kinto-Shibahara S; Haraguchi R; Kohara Y; Kitazawa S
Biochem Biophys Res Commun; 2019 Jul; 515(2):268-274. PubMed ID: 31146918
[TBL] [Abstract][Full Text] [Related]
33. Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2.
Guha M; Fang JK; Monks R; Birnbaum MJ; Avadhani NG
Mol Biol Cell; 2010 Oct; 21(20):3578-89. PubMed ID: 20719961
[TBL] [Abstract][Full Text] [Related]
34. The effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cells.
Kim JH; Kim EY; Lee B; Min JH; Song DU; Lim JM; Eom JW; Yeom M; Jung HS; Sohn Y
Int J Mol Med; 2016 Mar; 37(3):649-58. PubMed ID: 26848104
[TBL] [Abstract][Full Text] [Related]
35. The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells.
Park HJ; Baek K; Baek JH; Kim HR
J Cell Physiol; 2015 Mar; 230(3):667-79. PubMed ID: 25187507
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a New Class of Cathepsin K Inhibitors in Rhizoma Drynariae as Potential Candidates for the Treatment of Osteoporosis.
Qiu ZC; Dong XL; Dai Y; Xiao GK; Wang XL; Wong KC; Wong MS; Yao XS
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999266
[No Abstract] [Full Text] [Related]
38. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
[TBL] [Abstract][Full Text] [Related]
39. Pim-1 regulates RANKL-induced osteoclastogenesis via NF-κB activation and NFATc1 induction.
Kim K; Kim JH; Youn BU; Jin HM; Kim N
J Immunol; 2010 Dec; 185(12):7460-6. PubMed ID: 21068407
[TBL] [Abstract][Full Text] [Related]
40. Novel extraneural role of neurite outgrowth inhibitor A: modulation of osteoclastogenesis via positive feedback regulation of nuclear factor of activated T cell cytoplasmic 1.
Lee Y; Kim HJ; Park CK; Kim WS; Lee ZH; Kim HH
J Bone Miner Res; 2012 May; 27(5):1043-54. PubMed ID: 22392845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
